VC Fund Dossiers

Acorn Pacific is the classic 'bridge fund' that actually delivers on the cross-border promise — they're not just marketing speak about Asia connections. Their track record shows real exits: 1 IPO and 5 acquisitions including key companies like NGINX, Crown Bioscience and Zhejiang Nuhui Health Technology. Derek Chau brings genuine operational chops from being a startup CEO himself, which founders appreciate. The Wu Fu Chen legacy gives them serious Silicon Valley street cred going back decades. But here's the thing — they have a portfolio of 30 companies spread thin across multiple markets, so don't expect white-glove attention. They're solid for founders who need real Asia-Pacific expansion help, not just another check.

This is Japan's steady-Eddie B2B tech fund that's been grinding for over a decade without much fanfare. Two solid IPOs (ABEJA at $85M, Datasection) and three exits show they can actually get companies to the finish line, which is rarer than you'd think in Japan's startup scene. Notably, they don't take board seats - either they're being respectful of founder control or they're not hands-on enough to warrant it. The partners have been at this since 2013 and seem genuinely focused on the entrepreneur-first approach rather than flashy marketing. However, their exit rate is 13 percentage points lower than comparable VCs, so they might be too patient or not selective enough. If you're a B2B SaaS startup in Japan, they're a safe bet who won't micromanage you, but don't expect them to be your strategic rocket fuel either.

BII is the textbook 'relationship investor' - they genuinely mean it when they say they're in it for the long haul. Portfolio companies rave about them being 'first institutional check' partners who help expand globally, even placing former BII principals as CFOs. Founders say BII 'stood by us through every funding round and major business pivot' - that's not marketing speak, that's real commitment. With 3 unicorns (Shiprocket, Licious, Eruditus) in their portfolio, they've proven they can spot and nurture winners. The $500M committed through 2026 shows serious firepower. The downside? Their 'highly selective' approach means they pass on a lot - if you don't fit their thesis perfectly, you're probably out.